Zydus Lifesciences Shareholding

Zydus Lifesciences Ltd Shareholding Pattern

The Zydus Lifesciences Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Zydus Lifesciences Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE, BSE: 532321) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Zydus Lifesciences Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Zydus Lifesciences Ltd Shareholding Pattern (Latest)

The latest Zydus Lifesciences Ltd shareholding for Dec 2025 is:

• Promoters: 75.00%
• FII: 7.06%
• DII: 11.09%
• Public: 6.85%
• Government: 0.00%

Promoter holding in Zydus Lifesciences Ltd has increased, indicating strong confidence from company promoters.

Zydus Lifesciences Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Zydus Lifesciences Ltd.

• Dec 2025: 75.00%
• Sept 2025: 74.99%
• Jun 2025: 74.99%
• Mar 2025: 74.99%
• Dec 2024: 74.98%

Promoter stake in Zydus Lifesciences Ltd has increased, indicating strong long-term confidence.

Zydus Lifesciences Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Zydus Lifesciences Ltd.

• Dec 2025: 7.06%
• Sept 2025: 7.34%
• Jun 2025: 7.13%
• Mar 2025: 7.32%
• Dec 2024: 7.53%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Zydus Lifesciences Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 11.09%
• Sept 2025: 10.86%
• Jun 2025: 11.13%
• Mar 2025: 11.01%
• Dec 2024: 10.65%

DII stake in Zydus Lifesciences Ltd has increased over time, indicating growing domestic institutional confidence.

Zydus Lifesciences Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 6.85%
• Sept 2025: 6.80%
• Jun 2025: 6.74%
• Mar 2025: 6.68%
• Dec 2024: 6.84%

Public participation in Zydus Lifesciences Ltd has increased, indicating rising retail investor interest.

Zydus Lifesciences Ltd Government Holding

Government holding in Zydus Lifesciences Ltd currently stands at 0.00%.

Zydus Lifesciences Ltd operates without significant government ownership.

Zydus Lifesciences Ltd Shareholding Analysis Summary

The Zydus Lifesciences Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Zydus Lifesciences Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Zydus Lifesciences Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.